NICE (NICE) Stock Forecast, Price Target & Predictions
NICE Stock Forecast
NICE stock forecast is as follows: an average price target of $268.42 (represents a 58.37% upside from NICE’s last price of $169.49) and a rating consensus of 'Buy', based on 9 wall street analysts offering a 1-year stock forecast.
NICE Price Target
The average price target for NICE (NICE) is $268.42 based on 1-year price targets from 9 Wall Street analysts in the past 3 months, with a price target range of $343.00 to $225.00. This represents a potential 58.37% upside from NICE's last price of $169.49.
NICE Analyst Ratings
According to 9 Wall Street analysts, NICE's rating consensus is 'Buy'. The analyst rating breakdown for NICE stock is 0 'Strong Buy' (0.00%), 9 'Buy' (100.00%), 0 'Hold' (0.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
NICE Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Aug 16, 2024 | Daniel Ives | Wedbush | $250.00 | $174.37 | 43.37% | 47.50% |
| Aug 16, 2024 | Rishi Jaluria | RBC Capital | $260.00 | $174.37 | 49.11% | 53.40% |
| Jun 12, 2024 | James Fish | Piper Sandler | $238.00 | $174.94 | 36.05% | 40.42% |
| Jun 12, 2024 | Catharine Trebnick | Rosenblatt Securities | $225.00 | $174.94 | 28.62% | 32.75% |
| Jun 12, 2024 | Rishi Jaluria | RBC Capital | $230.00 | $175.42 | 31.11% | 35.70% |
| May 17, 2024 | Tavy Rosner | Barclays | $320.00 | $193.55 | 65.33% | 88.80% |
| May 17, 2024 | Siti Panigrahi | Mizuho Securities | $280.00 | $198.60 | 40.99% | 65.20% |
| May 17, 2024 | Rishi Jaluria | RBC Capital | $265.00 | $198.60 | 33.43% | 56.35% |
| May 16, 2024 | Nawar Cristini | Morgan Stanley | $290.00 | $198.60 | 46.02% | 71.10% |
| May 16, 2024 | Rishi Jaluria | RBC Capital | $285.00 | $198.60 | 43.50% | 68.15% |
The latest NICE stock forecast, released on Aug 16, 2024 by Daniel Ives from Wedbush, set a price target of $250.00, which represents a 43.37% increase from the stock price at the time of the forecast ($174.37), and a 47.50% increase from NICE last price ($169.49).
NICE Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | 2 | 15 |
| Avg Price Target | - | $255.00 | $271.33 |
| Last Closing Price | $169.49 | $169.49 | $169.49 |
| Upside/Downside | -100.00% | 50.45% | 60.09% |
In the current month, the average price target of NICE stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to NICE's last price of $169.49. This month's average price target is down -100.00% compared to last quarter, and down -100.00% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Oct 03, 2024 | Rosenblatt Securities | Underperform | Underperform | Hold |
| Oct 03, 2024 | Wedbush | Buy | Buy | Hold |
| Aug 16, 2024 | Wedbush | Outperform | Outperform | Hold |
| Aug 16, 2024 | RBC Capital | Outperform | Outperform | Hold |
| Jul 25, 2024 | Rosenblatt Securities | Underperform | Underperform | Hold |
| Jul 25, 2024 | Wedbush | Buy | Buy | Hold |
| Jun 12, 2024 | Wedbush | Market Outperform | Market Outperform | Hold |
| Jun 12, 2024 | Rosenblatt Securities | Underperform | Underperform | Hold |
| Jun 12, 2024 | Citigroup | Buy | Buy | Hold |
| Jun 12, 2024 | Piper Sandler | Overweight | Overweight | Hold |
NICE's last stock rating was published by Rosenblatt Securities on Oct 03, 2024. The company gave NICE a "Underperform" rating, the same as its previous rate.
NICE Financial Forecast
NICE Revenue Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $571.86M | $568.56M | $554.72M | $530.58M | $527.43M | $515.47M | $490.40M | $456.03M | $455.02M | $434.58M | $409.83M | $393.18M | $410.43M | $430.21M | $386.26M |
| Avg Forecast | $871.44M | $832.08M | $802.85M | $789.62M | $800.97M | $760.89M | $738.21M | $728.87M | $720.71M | $683.55M | $664.10M | $655.41M | $616.83M | $595.00M | $579.30M | $563.97M | $569.69M | $548.82M | $525.01M | $510.92M | $496.36M | $465.73M | $450.30M | $451.08M | $433.34M | $408.04M | $392.15M | $410.10M | $429.50M | $385.17M |
| High Forecast | $871.44M | $832.08M | $802.85M | $789.62M | $800.97M | $760.89M | $738.21M | $728.87M | $720.71M | $685.58M | $664.10M | $655.41M | $620.24M | $596.81M | $579.30M | $563.97M | $569.69M | $548.82M | $525.01M | $510.92M | $496.36M | $465.73M | $450.30M | $451.08M | $433.34M | $408.04M | $392.15M | $410.10M | $429.50M | $385.17M |
| Low Forecast | $871.44M | $832.08M | $802.85M | $789.62M | $800.97M | $760.89M | $738.21M | $728.87M | $720.71M | $681.63M | $664.10M | $655.41M | $612.43M | $589.81M | $579.30M | $563.97M | $569.69M | $548.82M | $525.01M | $510.92M | $496.36M | $465.73M | $450.30M | $451.08M | $433.34M | $408.04M | $392.15M | $410.10M | $429.50M | $385.17M |
| # Analysts | 9 | 9 | 9 | 9 | 8 | 8 | 8 | 8 | 9 | 10 | 9 | 4 | 7 | 11 | 5 | 9 | 5 | 4 | 4 | 7 | 5 | 5 | 10 | 7 | 5 | 9 | 9 | 9 | 8 | 8 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.01% | 1.00% | 1.01% | 1.01% | 1.03% | 1.04% | 1.05% | 1.01% | 1.01% | 1.00% | 1.00% | 1.00% | 1.00% | 1.00% | 1.00% |
NICE's average Quarter revenue forecast for Jun 23 based on 5 analysts is $579.30M, with a low forecast of $579.30M, and a high forecast of $579.30M. NICE's average Quarter revenue forecast represents a 1.30% increase compared to the company's last Quarter revenue of $571.86M (Mar 23).
NICE EBITDA Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 9 | 9 | 9 | 9 | 8 | 8 | 8 | 8 | 9 | 10 | 9 | 4 | 7 | 11 | 5 | 9 | 5 | 4 | 4 | 7 | 5 | 5 | 10 | 7 | 5 | 9 | 9 | 9 | 8 | 8 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $135.35M | $135.29M | $132.89M | $126.89M | $116.64M | $104.72M | $106.79M | $101.21M | $108.01M | $109.36M | $106.52M | $102.34M | $101.31M | $121.52M | $99.88M |
| Avg Forecast | $217.19M | $207.38M | $200.10M | $196.80M | $199.63M | $189.64M | $183.99M | $181.66M | $179.63M | $170.36M | $165.52M | $134.27M | $153.74M | $148.30M | $144.38M | $122.06M | $129.37M | $136.79M | $130.85M | $110.97M | $123.71M | $116.08M | $112.23M | $104.38M | $108.00M | $101.70M | $97.74M | $99.78M | $107.05M | $96.00M |
| High Forecast | $217.19M | $207.38M | $200.10M | $196.80M | $199.63M | $189.64M | $183.99M | $181.66M | $179.63M | $170.87M | $165.52M | $161.12M | $154.59M | $148.75M | $144.38M | $146.48M | $155.24M | $136.79M | $130.85M | $133.16M | $123.71M | $116.08M | $112.23M | $125.26M | $108.00M | $101.70M | $97.74M | $119.73M | $107.05M | $96.00M |
| Low Forecast | $217.19M | $207.38M | $200.10M | $196.80M | $199.63M | $189.64M | $183.99M | $181.66M | $179.63M | $169.89M | $165.52M | $107.42M | $152.64M | $147.00M | $144.38M | $97.65M | $103.50M | $136.79M | $130.85M | $88.77M | $123.71M | $116.08M | $112.23M | $83.51M | $108.00M | $101.70M | $97.74M | $79.82M | $107.05M | $96.00M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.11% | 1.05% | 0.97% | 0.97% | 1.05% | 0.85% | 0.92% | 0.90% | 1.03% | 1.01% | 1.05% | 1.05% | 1.02% | 1.14% | 1.04% |
5 analysts predict NICE's average Quarter EBITDA for Jun 23 to be $144.38M, with a high of $144.38M and a low of $144.38M. This is 6.67% upper than NICE's previous annual EBITDA (Mar 23) of $135.35M.
NICE Net Income Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 9 | 9 | 9 | 9 | 8 | 8 | 8 | 8 | 9 | 10 | 9 | 4 | 7 | 11 | 5 | 9 | 5 | 4 | 4 | 7 | 5 | 5 | 10 | 7 | 5 | 9 | 9 | 9 | 8 | 8 |
| Net Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $76.94M | $71.19M | $71.25M | $65.57M | $57.94M | $51.16M | $47.08M | $44.78M | $52.21M | $54.92M | $50.77M | $44.79M | $46.20M | $61.74M | $45.04M |
| Avg Forecast | $235.83M | $224.47M | $213.78M | $206.87M | $215.29M | $201.74M | $193.28M | $188.46M | $186.34M | $176.29M | $169.78M | $66.42M | $148.87M | $141.42M | $135.31M | $60.38M | $63.20M | $122.91M | $118.15M | $54.89M | $112.41M | $104.29M | $99.30M | $50.46M | $102.43M | $91.59M | $87.23M | $45.50M | $100.52M | $84.59M |
| High Forecast | $235.83M | $224.47M | $213.78M | $206.87M | $215.29M | $201.74M | $193.28M | $188.46M | $186.34M | $178.92M | $169.78M | $79.70M | $153.48M | $143.40M | $135.31M | $72.46M | $75.84M | $122.91M | $118.15M | $65.87M | $118.49M | $104.29M | $99.30M | $60.55M | $102.43M | $91.59M | $87.23M | $54.60M | $100.52M | $84.59M |
| Low Forecast | $235.83M | $224.47M | $213.78M | $206.87M | $215.29M | $201.74M | $193.28M | $188.46M | $186.34M | $174.31M | $169.77M | $53.13M | $144.92M | $138.13M | $135.31M | $48.30M | $50.56M | $122.91M | $118.15M | $43.91M | $106.33M | $104.29M | $99.30M | $40.37M | $102.43M | $91.59M | $87.23M | $36.40M | $100.52M | $84.59M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.27% | 1.13% | 0.58% | 0.56% | 1.06% | 0.46% | 0.45% | 0.45% | 1.03% | 0.54% | 0.55% | 0.51% | 1.02% | 0.61% | 0.53% |
NICE's average Quarter net income forecast for Jun 23 is $135.31M, with a range of $135.31M to $135.31M. NICE's average Quarter net income forecast represents a 75.87% increase compared to the company's last Quarter net income of $76.94M (Mar 23).
NICE SG&A Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 9 | 9 | 9 | 9 | 8 | 8 | 8 | 8 | 9 | 10 | 9 | 4 | 7 | 11 | 5 | 9 | 5 | 4 | 4 | 7 | 5 | 5 | 10 | 7 | 5 | 9 | 9 | 9 | 8 | 8 |
| SG&A | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $213.66M | $217.79M | $219.60M | $207.49M | $211.49M | $209.83M | $190.91M | $179.33M | $181.53M | $157.53M | $142.81M | $137.90M | $148.93M | $153.06M | $138.58M |
| Avg Forecast | $323.82M | $309.20M | $298.34M | $293.42M | $297.64M | $282.74M | $274.32M | $270.85M | $267.81M | $254.00M | $246.78M | $242.43M | $229.21M | $221.10M | $215.27M | $220.39M | $259.22M | $203.94M | $195.09M | $200.35M | $184.45M | $173.07M | $167.33M | $175.44M | $161.03M | $151.63M | $145.72M | $146.67M | $159.60M | $143.13M |
| High Forecast | $323.82M | $309.20M | $298.34M | $293.42M | $297.64M | $282.74M | $274.32M | $270.85M | $267.81M | $254.76M | $246.78M | $290.91M | $230.48M | $221.77M | $215.27M | $264.47M | $311.06M | $203.94M | $195.09M | $240.43M | $184.45M | $173.07M | $167.33M | $210.53M | $161.03M | $151.63M | $145.72M | $176.01M | $159.60M | $143.13M |
| Low Forecast | $323.82M | $309.20M | $298.34M | $293.42M | $297.64M | $282.74M | $274.32M | $270.85M | $267.81M | $253.29M | $246.78M | $193.94M | $227.58M | $219.17M | $215.27M | $176.31M | $207.38M | $203.94M | $195.09M | $160.28M | $184.45M | $173.07M | $167.33M | $140.35M | $161.03M | $151.63M | $145.72M | $117.34M | $159.60M | $143.13M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.97% | 0.84% | 1.08% | 1.06% | 1.06% | 1.14% | 1.10% | 1.07% | 1.03% | 0.98% | 0.94% | 0.95% | 1.02% | 0.96% | 0.97% |
NICE's average Quarter SG&A projection for Jun 23 is $215.27M, based on 5 Wall Street analysts, with a range of $215.27M to $215.27M. The forecast indicates a 0.75% rise compared to NICE last annual SG&A of $213.66M (Mar 23).
NICE EPS Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 9 | 9 | 9 | 9 | 8 | 8 | 8 | 8 | 9 | 10 | 9 | 4 | 7 | 11 | 5 | 9 | 5 | 4 | 4 | 7 | 5 | 5 | 10 | 7 | 5 | 9 | 9 | 9 | 8 | 8 |
| EPS | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $1.20 | $1.11 | $1.12 | $1.03 | $0.91 | $0.81 | $0.75 | $0.70 | $0.83 | $0.87 | $0.81 | $0.71 | $0.74 | $0.99 | $0.72 |
| Avg Forecast | $3.58 | $3.41 | $3.25 | $3.14 | $3.27 | $3.06 | $2.93 | $2.86 | $2.83 | $2.68 | $2.58 | $2.45 | $2.26 | $2.15 | $2.05 | $1.98 | $1.93 | $1.87 | $1.79 | $1.71 | $1.71 | $1.58 | $1.51 | $1.50 | $1.56 | $1.39 | $1.32 | $1.32 | $1.53 | $1.28 |
| High Forecast | $3.58 | $3.41 | $3.25 | $3.14 | $3.27 | $3.06 | $2.93 | $2.86 | $2.83 | $2.72 | $2.58 | $2.45 | $2.33 | $2.18 | $2.05 | $1.98 | $1.94 | $1.87 | $1.79 | $1.71 | $1.80 | $1.58 | $1.51 | $1.50 | $1.56 | $1.39 | $1.32 | $1.32 | $1.53 | $1.28 |
| Low Forecast | $3.58 | $3.41 | $3.25 | $3.14 | $3.27 | $3.06 | $2.93 | $2.86 | $2.83 | $2.65 | $2.58 | $2.45 | $2.20 | $2.10 | $2.05 | $1.98 | $1.92 | $1.87 | $1.79 | $1.71 | $1.61 | $1.58 | $1.51 | $1.50 | $1.56 | $1.39 | $1.32 | $1.32 | $1.53 | $1.28 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.61% | 0.58% | 0.60% | 0.57% | 0.53% | 0.47% | 0.47% | 0.46% | 0.55% | 0.56% | 0.58% | 0.54% | 0.56% | 0.65% | 0.56% |
According to 5 Wall Street analysts, NICE's projected average Quarter EPS for Jun 23 is $2.05, with a low estimate of $2.05 and a high estimate of $2.05. This represents a 71.23% increase compared to NICE previous annual EPS of $1.20 (Mar 23).
NICE Forecast FAQ
Is NICE a good buy?
Yes, according to 9 Wall Street analysts, NICE (NICE) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 9 'Buy' recommendations, accounting for 100.00% of NICE's total ratings.
What is NICE's price target?
NICE (NICE) average price target is $268.42 with a range of $225 to $343, implying a 58.37% from its last price of $169.49. The data is based on 9 Wall Street analysts who provided a twelve-month price target estimate in the last three months.
Will NICE stock go up soon?
According to Wall Street analysts' prediction for NICE stock, the company can go up by 58.37% (from the last price of $169.49 to the average price target of $268.42), up by 102.37% based on the highest stock price target, and up by 32.75% based on the lowest stock price target.
Can NICE stock reach $300?
NICE's highest twelve months analyst stock price target of $343 supports the claim that NICE can reach $300 in the near future.
What are NICE's analysts' financial forecasts?
NICE's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $3.03B (high $3.03B, low $3.03B), average EBITDA is $754.92M (high $754.92M, low $754.92M), average net income is $798.77M (high $798.77M, low $798.77M), average SG&A $1.13B (high $1.13B, low $1.13B), and average EPS is $12.13 (high $12.13, low $12.13). NICE's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $3.3B (high $3.3B, low $3.3B), average EBITDA is $821.48M (high $821.48M, low $821.48M), average net income is $880.95M (high $880.95M, low $880.95M), average SG&A $1.22B (high $1.22B, low $1.22B), and average EPS is $13.38 (high $13.38, low $13.38).
Did the NICE's actual financial results beat the analysts' financial forecasts?
Based on NICE's last annual report (Dec 2022), the company's revenue was $2.18B, beating the average analysts forecast of $2.15B by 1.25%. Apple's EBITDA was $511.72M, beating the average prediction of $507.98M by 0.74%. The company's net income was $265.94M, missing the average estimation of $359.15M by -25.95%. Apple's SG&A was $856.36M, missing the average forecast of $858.61M by -0.26%. Lastly, the company's EPS was $4.17, missing the average prediction of $7.3 by -42.84%. In terms of the last quarterly report (Mar 2023), NICE's revenue was $571.86M, beating the average analysts' forecast of $563.97M by 1.40%. The company's EBITDA was $135.35M, beating the average prediction of $122.06M by 10.89%. NICE's net income was $76.94M, beating the average estimation of $60.38M by 27.43%. The company's SG&A was $213.66M, missing the average forecast of $220.39M by -3.06%. Lastly, the company's EPS was $1.2, missing the average prediction of $1.98 by -39.25%